2000•He'nan zhongliuxue zazhiRequires access

Clinical Analysis of the Short-term Efficacy and Toxicity of the Advanced Gastric Cancer Treated with ELFP Regimen and EFP Regimen

Jian Li Jiang

Open publisher page 0 citations

Abstract

Objective To evaluate the efficacy and toxicity of ELFP and EFP regimen in the treatment of advanced gastric cancer.Method 63 patients treated with ELFP regimen were equally divided into three groups [the low-dose CF (leucovorin) group, the median-dose CF group and the high-dose CF group];21 patients were treated with EFP regimen. Results Response rates were 65.1% (41/63) and 42.9%(9/21),respectively for these two regimens. Besides, response rates were 61.9%(13/21), 66.6%(14/21) and 66.6%(14/21),separataly for these three gruops in ELFP regimen. There was notable statistical difference between ELFP regimen and EFP regimen, but no statstical difference among these three groups.Conclusion ELFP regimen is regarded as a better regimen for advanved gastric cancer.

About this research paper

What this paper is about

Objective To evaluate the efficacy and toxicity of ELFP and EFP regimen in the treatment of advanced gastric cancer.Method 63 patients treated with ELFP regimen were equally divided into three groups [the low-dose CF (leucovorin) group, the median-dose CF group and the high-dose CF group];21 patients were treated with EFP regimen. Results Response rates were 65.1% (41/63) and 42.9%(9/21),respectively for these two regimens. Besides, response rates were 61.9%(13/21), 66.6%(14/21) and 66.6%(14/21),separataly for these three gruops in ELFP regimen. There was notable statistical difference between ELFP regimen and EFP regimen, but no statstical difference among these three groups.Conclusion ELFP regimen is regarded as a better regimen for advanved gastric cancer.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the efficacy and toxicity of ELFP and EFP regimen in the treatment of advanced gastric cancer.Method 63 patients treated with ELFP regimen were equally divided into three groups [the low-dose CF (leucovorin) group, the median-dose CF group and the high-dose CF group];21 patients were treated with EFP regimen. Results Response rates were 65.1% (41/63) and 42.9%(9/21),respectively for these two regimens. Besides, response rates were 61.9%(13/21), 66.6%(14/21) and 66.6%(14/21),separataly for these three gruops in ELFP regimen. There was notable statistical difference between ELFP regimen and EFP regimen, but no statstical difference among these three groups.Conclusion ELFP regimen is regarded as a better regimen for advanved gastric cancer.

Key concepts: Regimen, Medicine, Toxicity, Internal medicine, Significant difference, Gastroenterology, Surgery

Back to paper searchBrowse research topicsOriginal source
Clinical Analysis of the Short-term Efficacy and Toxicity of the Advanced Gastric Cancer Treated with ELFP Regimen and EFP Regimen — Research Paper | ScholarLens